Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. Medistim ASA
  6. News
  7. Summary
    MEDI   NO0010159684

MEDISTIM ASA

(MEDI)
  Report
Real-time Quote. Real-time Oslo Bors - 12/03 10:25:19 am
325.5 NOK   -3.56%
11/16Management in Medistim ASA purchases shares
AQ
10/29MEDISTIM ASA : Disclosure of large shareholding
AQ
10/22MEDISTIM : Results for the Third Quarter 2021
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Medistim : Results for the Third Quarter 2021

10/22/2021 | 04:24am EST

Sales revenues for the quarter ended at MNOK 102.1 (MNOK 83.4), an increase of 22.5%. Sales as of September ended at MNOK 309.2 (MNOK 268.9) a 15.0% increase. Sales in the USA increased by 11.9 % in NOK. Currency neutral growth was 24.9%. Currency neutral sales of own products increased by 33% for the quarter. Operating result (EBIT) for the quarter ended at MNOK 25.1 (MNOK 20.8) a 20.3% increase. EBIT year to date September ended at MNOK 96.8 (MNOK 73.3), a 32.0% increase. This is the best operating result YTD September ever.
Read the full report and presentation below:

Q3 2021 Report

Q3 2021 Presentation

Disclaimer

Medistim ASA published this content on 22 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 October 2021 08:23:11 UTC.


ę Publicnow 2021
All news about MEDISTIM ASA
11/16Management in Medistim ASA purchases shares
AQ
10/29MEDISTIM ASA : Disclosure of large shareholding
AQ
10/22MEDISTIM : Results for the Third Quarter 2021
PU
10/22MEDISTIM : Third quarter results 2021 for Medistim ASA
AQ
10/21Medistim ASA Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
CI
10/19MEDISTIM : Pivotal consensus statement for Medistim's transit time flow technology (TTFM) ..
PU
10/19MEDISTIM : Pivotal consensus statement for Medistim's transit time flow technology (TTFM) ..
AQ
10/18MEDISTIM : Presentation of third quarter results 2021 for Medistim ASA
AQ
09/20MEDISTIM ASA(OB : MEDI) dropped from S&P Global BMI Index
CI
08/13MEDISTIM : Notification of trade primary insider
AQ
More news
Financials
Sales 2021 431 M 47,0 M 47,0 M
Net income 2021 99,8 M 10,9 M 10,9 M
Net cash 2021 49,4 M 5,38 M 5,38 M
P/E ratio 2021 59,3x
Yield 2021 1,18%
Capitalization 5 928 M 646 M 646 M
EV / Sales 2021 13,6x
EV / Sales 2022 11,8x
Nbr of Employees 122
Free-Float 84,1%
Chart MEDISTIM ASA
Duration : Period :
Medistim ASA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDISTIM ASA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 325,50 NOK
Average target price 392,50 NOK
Spread / Average Target 20,6%
EPS Revisions
Managers and Directors
Kari Eian Krogstad President & Chief Executive Officer
Thomas Kure Jakobsen Chief Financial Officer
ěyvin Anders Br°ymer Chairman
Erik Swensen Vice President-Research & Development
Anne Waaler Vice President-Medical Department
Sector and Competitors
1st jan.Capi. (M$)
MEDISTIM ASA35.00%646
THERMO FISHER SCIENTIFIC36.57%250 658
DANAHER CORPORATION40.88%223 620
INTUITIVE SURGICAL, INC.20.03%114 898
SIEMENS HEALTHINEERS AG52.50%80 761
EDWARDS LIFESCIENCES CORPORATION20.38%67 728